You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 11, 2025

Bulk Pharmaceutical API Sources for SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ⤷  Get Started Free 204439_ALDRICH ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 310166_SIAL ⤷  Get Started Free
Sigma-Aldrich ⤷  Get Started Free 378860_ALDRICH ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Last updated: August 17, 2025

lk Active Pharmaceutical Ingredient (API) Sources for: SODIUM CHLORIDE 0.9% IN STERILE PLASTIC CONTAINER

Introduction
Sodium chloride 0.9%, commonly referred to as normal saline, is a vital API extensively utilized in intravenous (IV) therapy, fluid replacement, and drug formulations. Its widespread application across healthcare settings necessitates a reliable supply chain from reputable manufacturers. This analysis explores the key bulk API sources globally, highlighting their capabilities, quality standards, regulatory compliance, and market positioning to assist stakeholders in sourcing this critical pharmaceutical ingredient effectively.


Overview of Sodium Chloride 0.9% API in Sterile Containers
Sodium chloride 0.9% in sterile plastic containers is precisely formulated and manufactured to meet stringent pharmacopoeial standards, ensuring safety, efficacy, and quality. The manufacturing process involves complex dissolution and sterilization techniques, often utilizing advanced aseptic processing within controlled environments. As a sterile parenteral product, the API must adhere to Good Manufacturing Practice (GMP) guidelines, with suppliers demonstrating compliance with international standards such as USP, EP, and JP.


Leading Global API Suppliers for Sodium Chloride 0.9%

1. Baxter International Inc.

Overview:
Baxter is a pioneering global healthcare company specializing in sterile solutions and APIs. The company's GMP-certified facilities provide high-quality sodium chloride APIs, supplying both bulk and finished product markets.

Capabilities:

  • Supply of pharmaceutical-grade sodium chloride with high purity suitable for infusion fluids.
  • Manufacturing within ISO 9001, ISO 13485, and GMP-compliant facilities.
  • Extensive distribution channels across North America, Europe, and Asia.

Quality & Compliance:
Baxter maintains rigorous quality assurance procedures, including in-process testing, validation, and stability programs, ensuring products meet USP and EP specifications.

2. Fuso Pharmaceutical Industries Ltd.

Overview:
A Japanese manufacturer recognized for its high-quality pharmaceutical raw materials, including sodium chloride for parenteral solutions.

Capabilities:

  • Produces pharmaceutical-grade sodium chloride API compliant with USP, EP, and JP standards.
  • Focuses on sterile production processes with robust sterilization and aseptic techniques.
  • Certified for ISO 9001 and GMP standards.

Market Presence:
Fuso's regional strength in Asia and partnerships with international distributors make it a reliable source for global supply chains.

3. LGM Pharma

Overview:
LGM Pharma is a North American distributor of bulk pharmaceutical ingredients, including sodium chloride 0.9%. They act as an intermediary sourcing partner for global manufacturers.

Capabilities:

  • Sourcing from multiple certified API manufacturers worldwide.
  • Emphasis on quality assurance, regulatory documentation, and raw material traceability.
  • Offers custom packaging and documentation tailored to client needs.

Compliance:
LGM Pharma ensures all supplied APIs meet FDA, USP, EP, and other international standards, with comprehensive Certificates of Analysis (CoA) supplied upon request.

4. Puleva Biotech

Overview:
A European-based manufacturer specializing in high-purity salts and electrolytes, including sodium chloride for pharmaceutical applications.

Capabilities:

  • GMP-compliant production, with a focus on sterile, injectable-grade sodium chloride.
  • Large-scale manufacturing facilities supporting global supply.

Quality Standards:
Adheres to strict ISO standards and maintains compliance with EMA regulations.

5. Hospira (A Pfizer Company)

Overview:
A recognized leader in sterile injectable pharmaceuticals, Hospira supplies sodium chloride APIs primarily for hospital and institutional use.

Capabilities:

  • Reliable supply chain with stringent quality control measures.
  • Extensive experience in sterile processing and aseptic manufacturing.
  • Provides APIs that align with USP, EP, and JP pharmacopeial standards.

Regional and Market Considerations

North America

The US hosts a mature API market with Baxter and Hospira leading in API manufacturing and supply. Regulatory requirements under the FDA enforce strict quality and safety standards, ensuring robust quality assurance systems.

Europe

European suppliers like Puleva Biotech and Fuso are compliant with EMA guidelines, making them attractive for markets requiring EU-GMP certification. These suppliers benefit from proximity and adherence to strict European standards.

Asia

India and Japan are key players. Indian companies, such as Signet Industries and other GMP-certified manufacturers, serve as bulk API sources through established distribution channels, often at competitive prices. Japanese firms, like Fuso, emphasize high-quality sterile processes.


Regulatory and Quality Assurance Factors
Sourcing sodium chloride 0.9% API requires adherence to international pharmacopeial standards. Buyers should verify certifications such as GMP, ISO 9001/13485, and compliance with USP, EP, and JP standards. Due diligence involves reviewing Certificates of Analysis, Sterility Certification, and stability data.

Manufacturers capable of providing documentation supporting sterile manufacturing processes, sterilization validation, and endotoxin testing enhance procurement confidence. The API should also be traceable back to validated production lots, with clearly documented supply chain integrity.


Supply Chain Challenges and Mitigation Strategies

  • Global shortages: Periodic shortages can disrupt supply; diversification of suppliers mitigates risk.
  • Regulatory changes: Staying aligned with evolving standards ensures compliance; engaging with suppliers on compliance programs is critical.
  • Price fluctuations: Long-term contracts and bulk purchasing arrangements can stabilize costs.

Conclusion
The global sodium chloride 0.9% API market comprises several reputable manufacturers and distributors prioritizing quality, sterility, and regulatory compliance. Establishing relationships with certified suppliers—such as Baxter, Fuso, Puleva, and Hospira—ensures a reliable supply for sterile applications. Incorporating rigorous due diligence processes, including certification verification and quality audits, optimizes procurement strategies and reduces supply chain risks for pharmaceutical entities.


Key Takeaways

  • Reputable API suppliers include Baxter, Fuso, Puleva, Hospira, and LGM Pharma, with global footprints and stringent quality controls.
  • Due diligence across certifications, compliance standards, and sterilization validation remains fundamental to sourcing sterile sodium chloride API.
  • Diversification of suppliers mitigates risks associated with shortages and regulatory shifts.
  • Regional considerations influence supplier selection, with North America, Europe, and Asia presenting distinct advantages.
  • Proactive supply chain management and contractual safeguards are essential to ensuring uninterrupted access to high-quality sodium chloride 0.9% API.

FAQs

1. What are the main quality standards for sodium chloride 0.9% API in sterile containers?
The primary standards include USP, EP, and JP, which specify purity, sterility, endotoxin levels, and dissolution parameters. Suppliers must demonstrate GMP compliance and provide Certificates of Analysis verifying adherence.

2. How do I verify the sterilization process of the sodium chloride API?
Request detailed sterilization validation documentation, including sterilization method (e.g., autoclaving, filtration), biological indicators, endotoxin testing results, and validation reports.

3. Can I source sodium chloride API from multiple regions?
Yes; sourcing from diverse regions—North America, Europe, and Asia—diversifies supply risks, but each supplier must meet your quality, regulatory, and logistical requirements.

4. What role does regulatory compliance play in supplier selection?
Regulatory compliance ensures product safety and efficacy, enables easier approval across markets, and reduces legal and quality risks. Ensure suppliers possess necessary GMP certifications and pharmacopeial compliance.

5. How does market demand influence pricing and supply stability?
High demand may lead to price fluctuations and supply constraints. Long-term agreements, early engagement, and inventory planning are recommended to maintain stable supply lines.


Sources
[1] US Pharmacopeia (USP) , “Sterile Preparation Documentation,” 2022.
[2] European Pharmacopoeia (EP) , “Monograph on Sodium Chloride for Injections,” 2022.
[3] World Health Organization (WHO), “Guidelines for Pharmaceutical Quality Assurance,” 2021.
[4] Baxter International, Product Data Sheets & GMP Compliance Certifications, 2022.
[5] Fuso Pharmaceutical Industries, GMP Certification & Product Literature, 2022.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.